Location
United States, North America
Check Size
$250K - $20M
Investment Stage
Seed
Series A
Focus Areas
BioTech
Pharmaceuticals
About Investor
Colleen Cuffaro is a Partner at Canaan Partners, where she focuses on life sciences and healthcare. She invests in biotech and pharmaceuticals at seed and Series A stages, with checks ranging from $250K to $20 M. Cuffaro holds a PhD in pharmacology from Yale University and has built her career at Canaan around advancing breakthrough therapies. She combines scientific training with venture experience to support early-stage biotech founders.
Previous investments
CatalYm
150M |2024
AgomAb Therapeutics
100M |2023
Comet Therapeutics
29M |2019
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP